19.03.2021: What tools do National health systems have at their disposal to further reward the development and uptake of much needed new antibiotics and diagnostics? Undertaken by the team at the Austrian Institute of Public Health (GÖG), the Global AMR R&D Hub is happy to publicly-release this important study today. This comprehensive review of available policy tools within pricing, reimbursement and procurement in ten G20 countries, includes concrete examples and suggestions for learning, leverage and implementation. This is one of three studies that were used to derive our recently-published recommendations put forward to the G7 and G20 for their ongoing reflections. Download the full report here and the accompanying policy brief here.
04.02.2025
New Publication in Vaccine
Vaccines play a vital role in preventing infections and reducing antibiotic use, making them essential tools in the fight against antimicrobial resistance (AMR). Given that AMR disproportionately impacts Low- and Middle-Income Countries (LMICs), this study provides this first comprehensive analysis of global investments in bacterial vaccine research and development (R&D) in LMICs.